323196-38-9Relevant articles and documents
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
-
Page/Page column 92; 93, (2016/06/28)
Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, and pharmaceutical compositions and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
2-Azidoethoxy derivatives of 2-aminocyclohexanecarboxylic acids (ACHC): Interesting building blocks for the synthesis of cyclic β-peptide conjugates
Reina, Jose J.,Bernardi, Anna
scheme or table, p. 5770 - 5775 (2011/09/12)
Oligomers of cyclic-β-aminoacids possess a high resistance to peptidase-catalyzed hydrolysis and display a high intrinsic tendency to adopt regular secondary structures. These characteristics are attractive to develop new biologically active substances. H